HIMENSION CAPITAL (SINGAPORE) PTE. LTD.
Position in NTLA — Intellia Therapeutics, Inc.
CIK 1817652
SINGAPORE, U0
Position in NTLA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,531,029
+$24,327 QoQ
Shares Held
326,893
-23.9% QoQ
Ownership
0.233%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#55
of 329 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HIMENSION CAPITAL (SINGAPORE) PTE. LTD. holds $26,011,934 across 20 Biotechnology names. NTLA ranks #1 (21.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTLA |
Intellia Therapeutics, Inc.
This page
|
326,893 | $5,531,029 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
18,136 | $5,459,480 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
83,897 | $4,575,742 | |
| 4 | MRNA |
Moderna, Inc.
|
25,218 | $1,766,016 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
36,419 | $1,249,900 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
5,653 | $1,058,693 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
50,111 | $937,576 | |
| 8 | ABVX |
Abivax S.A.
|
4,591 | $611,796 |
All Filings in NTLA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,531,029 | 326,893 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,506,702 | 429,540 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,201,272 | 578,562 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,759,795 | 565,130 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,841,968 | 729,421 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,351,526 | 752,676 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $11,493,436 | 985,715 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $22,105,861 | 1,075,711 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $23,050,997 | 1,029,982 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $28,352,383 | 1,030,621 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $31,423,634 | 1,030,621 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $36,207,777 | 1,145,091 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $46,696,810 | 1,145,091 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $42,677,541 | 1,145,091 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $39,952,224 | 1,145,091 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $66,659,160 | 1,191,193 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $62,957,758 | 1,216,340 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $54,078,107 | 744,160 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $69,789,977 | 590,240 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $56,458,234 | 420,859 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $48,625,944 | 300,327 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,855,495 | 23,120 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||